SEC Filing Analysis: JOHNSON & JOHNSON (JNJ)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director received approximately $50,000 in Deferred Share Units (DSUs) as part of a standard compensation plan, representing a negligible fraction of the company's market capitalization.
• Market Impact: Neutral. This is a routine, non-discretionary transaction with no material impact on the stock.

Company Information

Field	Value
Company	JOHNSON & JOHNSON
Ticker Symbol	JNJ
CIK	0000200406
Industry	PHARMACEUTICAL PREPARATIONS

Insider Information

Field	Value
Name	HEWSON MARILLYN A
CIK	0001217496
Title/Position	null
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-12-09
Transaction Code	A (Grant)
Security Type	Deferred Share Units
Shares Involved	247.378
Price Per Share	$202.12
Total Value	$50,000.00
Shares Owned After	14,153.1187
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$50,000.00
% of Market Cap	0.00001%
Shares Transacted	247.378
% of Shares Outstanding	0.00001%
Post-Transaction Ownership	14,153.1187 shares (0.0006% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For a mega-cap company with a market capitalization of $472.05 billion, a $50,000 transaction is financially immaterial.
• Ownership Concentration: The director's total holdings of 14,153 units represent a very small fraction (0.0006%) of the total shares outstanding, indicating low ownership concentration from this individual.
• Dilution Impact: As this is an acquisition of DSUs (a derivative security), there is no immediate dilution. The number of shares is negligible compared to the 2.4 billion shares outstanding.
• Transaction Significance: The transaction's value is less than 0.0001% of the market cap, and the shares involved are less than 0.0001% of shares outstanding. This is a routine administrative filing with no trading significance.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction is a non-discretionary award as part of a director's compensation plan. It does not signal any change in the insider's sentiment or outlook on the company.

Volume & Sentiment

• Expected Volume Impact: None. This is not an open-market transaction and will not affect trading volume.
• Sentiment Indicator: Neutral. This filing is informational and related to standard corporate governance procedures.

Additional Context

Transaction Notes

• Special Circumstances: Per Footnote 1, these Deferred Share Units were acquired for the deferral of a cash retainer under the company's Deferred Fee Plan for Directors. The units are settled in cash upon termination of the directorship.